Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-30

Clinical Trial Update: Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and tolerability of a Beclomethasone Dipropionate/Formoterol single inhaler in adults with mild to moderate persistent ast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beclomethasone Dipropionate/Formoterol (Beclomethasone dipropionate/formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED